Swiss Re introduces guidance for underwriters on repurposed longevity drugs
Reinsurance News - Aug 12, 2025
Swiss Re’s August 2025 Life Guide has introduced guidance for underwriters on how to assess life insurance applicants who show signs of using repurposed longevity drugs, an emerging trend among health-conscious individuals. The update provides new guidance on medications like metformin and rap...
Recommended Articles
Posted: Dec 08, 2025
Berkshire Hathaway, the Warren Buffett-run holding company and conglomerate, has named Nancy L. Pier...
Posted: Dec 08, 2025
Sorathia Holdings and Greenlight Re Innovations have joined as new investors for a Series A round of...
Posted: Dec 08, 2025
Following Onex Corporation’s sale of its remaining shares of Ryan Specialty Holdings, Inc., an inter...